Cardioprotection by regular ethanol consumption: potential mechanisms and clinical application

Area of Science:

• Cardiology
• Pharmacology
• Epidemiology

Background:

• Excessive alcohol consumption is linked to adverse cardiovascular outcomes like hypertension and reduced cardiac contractility.
• Moderate ethanol intake correlates with reduced mortality, particularly from ischemic heart disease and myocardial infarction, compared to abstainers.
• Ethanol's cardioprotective effects may stem from its influence on lipids, platelets, and fibrinolytic activity.

Purpose of the Study:

• To review recent advancements in understanding the endogenous signaling pathways in myocytes that mediate cardioprotection from light to moderate ethanol consumption.
• To explore how moderate ethanol intake impacts tolerance to myocardial ischemia-reperfusion injury and survival post-myocardial infarction.

Main Methods:

• Review of epidemiological studies and animal model research on ethanol consumption and cardiovascular health.
• Analysis of clinical evidence linking moderate ethanol intake to outcomes following myocardial infarction.
• Focus on endogenous myocyte signaling mechanisms involved in ethanol-induced cardioprotection.

Main Results:

• Light to moderate ethanol consumption confers tolerance to myocardial ischemia-reperfusion injury, comparable to ischemic preconditioning.
• Moderate ethanol consumers exhibit lower rates of myocardial infarction and reduced mortality post-myocardial infarction.
• Potential mechanisms include activation of adenosine A1 receptors, alpha(1)-adrenoceptors, protein kinase C, K(ATP) channels, and nitric oxide synthase.

Conclusions:

• Light to moderate ethanol consumption may prevent myocardial infarction and enhance survival rates.
• Ethanol-induced cardioprotection involves complex endogenous signaling pathways within cardiac myocytes.
• Further research into these signaling mechanisms can inform therapeutic strategies for cardiovascular protection.